[Potassium canreonate and myocardial hyperexitability].
作者信息
Warembourg H, Ducloux G
出版信息
Lille Med. 1974 Feb;19(2):186-92.
PMID:4603756
Abstract
摘要
相似文献
1
[Potassium canreonate and myocardial hyperexitability].[坎利酸钾与心肌兴奋性过高]
Lille Med. 1974 Feb;19(2):186-92.
2
The specificity of potassium canrenoate, a steroidal antidysrhythmic drug.甾体抗心律失常药物坎利酸钾的特异性。
Clin Pharmacol Ther. 1974 Dec;16(6):1014-22. doi: 10.1002/cpt19741661014.
3
[Anti-arrhythmic effect of competitive aldosterone antagonists].[竞争性醛固酮拮抗剂的抗心律失常作用]
Vrach Delo. 1984 Apr(4):18-22.
4
[Soludactone use in a cardiology department].[索鲁达酮在心内科的应用]
Bord Med. 1972 Sep;5(13):1605-10.
5
Clinical studies of Norpace (Part II).
Angiology. 1975 Jan;26(1 Pt 2):132-6.
6
[Bunaftine in the treatment of arrhythmias].
Cardiol Prat. 1975 Jan-Jun;26(1):29-36.
7
[Preliminary study on the antianginous and antiarrhythmic efficacy of a new benzofuran derivative: amiodarone].一种新型苯并呋喃衍生物（胺碘酮）抗心绞痛和抗心律失常疗效的初步研究
Minerva Cardioangiol. 1974 Feb;22(2):134-7.
8
[Polycentric clinical experimentation with a new anti-arrhythmia agent: bunaftide].
Boll Soc Ital Cardiol. 1972;17(11):1089-104.
9
[Hyperaldosteronism in the acute phase of myocardial infarction. Effects of its treatment on the prevention of ventricular fibrillation].[心肌梗死急性期的醛固酮增多症。其治疗对预防心室颤动的作用]
Arch Mal Coeur Vaiss. 1984 Apr;77 Spec No:35-40.
10
[Anti-arrhythmia activity and side effects of various anti-arrhythmia agents].
Vrach Delo. 1985 Mar(3):41-4.
Zotero 插件